Badger Meter, Inc. (BMI) is a Wisconsin-based provider of water management solutions, including water meters, flow measurement hardware, connectivity technology, and related software. On Tuesday, the stock fell 5.90%, trading around $146.75 compared with a prior-session close of $155.95. The decline reversed part of a sharp multi-session advance and followed a downgrade of the shares by a sell-side research firm, with markets also weighing the company's mixed third-quarter results released last week.
The most immediate catalyst for Tuesday's slide was a rating change. Northcoast Research downgraded BMI to Neutral from Buy, issuing the call without a new price target. Downgrades of this kind typically prompt near-term selling as some investors reduce positions and others pause before adding to holdings. The move comes against a backdrop of mixed analyst commentary on the name: while several firms raised price targets following earnings, at least one other research house recently moved to a more cautious stance. The conflicting signals contributed to a risk-off tone in the stock's trading on Tuesday.
The downgrade landed shortly after BMI reported third-quarter results on October 22. The company posted earnings per share of $1.24, narrowly topping the consensus estimate of $1.23, but revenue of approximately $230.3 million came in below the roughly $240.35 million analysts had expected. That combination — a modest earnings beat offset by a top-line miss — created a nuanced fundamental picture. Despite the revenue shortfall, shares rallied strongly in the days following the report, aided by upbeat margin commentary, software growth, a dividend increase, and ongoing share buybacks. Tuesday's decline therefore also reflects investors locking in gains after a roughly 20% run over the prior week, a classic "buy the rumor, sell the news" pattern as the initial enthusiasm cooled.
The pullback occurred on elevated trading activity relative to the stock's typical volume, consistent with a meaningful reassessment by institutional and retail participants. Even after Tuesday's decline, BMI remains above both its 50-day moving average and its 200-day moving average, suggesting that the longer-term uptrend has not yet been broken despite the day's weakness. The move was largely company-specific rather than driven by broad sector or index dynamics; the stock's reaction was tied to its own ratings and earnings news rather than a pronounced shift in the broader industrial or technology complex. Investors should view the move primarily through the lens of stock-specific catalysts.
Looking ahead, attention will focus on whether the revenue trajectory improves and whether the company's advanced metering infrastructure (AMI) and software initiatives can sustain margin expansion. Upcoming quarterly results and management commentary will be closely watched for signs of sales reacceleration, given the modest year-over-year revenue growth reported last quarter. Analyst expectations remain varied, with a spread of price targets reflecting differing views on valuation, which remains elevated by traditional metrics. Key risks include potential delays in awarded project ramps, competitive pressures in the water technology space, and the possibility of further rating changes. Traders will also monitor technical support levels to gauge whether Tuesday's decline marks a healthy consolidation or the start of a deeper correction.
Tickeron's Trending AI Robots page highlights a curated selection of automated trading strategies that are currently performing strongly. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under present market conditions are featured in this section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade. Traders looking for systematic, data-driven approaches may find value in exploring these tools as part of their research process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 41 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 62 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on October 09, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 184 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BMI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.620) is normal, around the industry mean (1.496). P/E Ratio (36.267) is within average values for comparable stocks, (6.275). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.011) settles around the average of (0.011) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments